Institutional investors purchased a net $58.5 million shares of ABBV during the quarter ended March 2015, and now own 76.31% of the total float, a percentage that is typical for companies in the Pharmaceuticals: Major industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
EATON VANCE MANAGEMENT Bought 1.3 Million shares of AbbVie
ARTEMIS INVESTMENT MANAGEMENT LL... Bought 1.0 Million shares of AbbVie
SMITH ASSET MANAGEMENT GROUP LP Bought 555.7 Thousand shares of AbbVie